human amniotic exosomes (Regenasome)

N/A

Report date: 2025/03/20 15:23:15

Base Information

Drug Namehuman amniotic exosomes (Regenasome)
Drug Alias Namehuman amniotic exosomes (Hudson Institute of Medical Research)
ClassificationBiologics > Exosomes
Mechanisms of ActionStem cells stimulants
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Hudson Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesRegenasome Pty LtdThe Hudson Institute Of Medical ResearchMonash University
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary FibrosisLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A